首頁 > 市場調查報告書 > 醫療設備

北美腦脊髓液管理市場預測至 2030 年 - 區域分析 - 按產品（腦脊髓液分流器和腦脊髓液引流系統）和最終用戶（醫院、診所、門診手術中心等）

市場調查報告書

商品編碼

1463657

北美腦脊髓液管理市場預測至 2030 年 - 區域分析 - 按產品（腦脊髓液分流器和腦脊髓液引流系統）和最終用戶（醫院、診所、門診手術中心等）

North America Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日期: 2024年01月22日 | 出版商:

The Insight Partners | 英文 80 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美腦脊髓液管理市值為8.0796億美元，預計2030年將達到12.4249億美元；預計2022年至2030年CAGR為5.5%。

腦脊髓液洩漏病例的增加推動了北美腦脊髓液管理市場的發展

根據《神經外科雜誌》報道，全球每年估計有超過 6,900 萬人遭受腦外傷。腦部和脊椎損傷是成人腦脊髓液 (CSF) 滲漏最常見的原因，因此需要進行腦脊髓液處理。高血壓主要是由於生活方式的改變和不健康習慣引起的，是成人和老年人腦脊髓液漏的另一個顯著原因。同樣，高血壓在老年人中很常見，這最終導致特發性顱內高壓（IIH）的風險增加。因此，老年人口的成長可能與北美腦脊髓液管理市場的成長有關。

世界各地腦積水的發生率正在顯著增加。腦積水的發生率在老年族群最高；值得注意的是，與成人相比，兒科族群的發生率更高。根據國家醫學圖書館 (NLM) 發表的一篇文章，全球腦積水盛行率約為每 10 萬人中 85 人。根據同一來源，兒科族群的盛行率約為每 10 萬人 11 人，老年人口的盛行率約為每 10 萬人 175 人。此外，低收入和中等收入國家的腦積水發生率為每 10 萬名新生兒約 123 例，而高收入國家的發生率為每 10 萬名新生兒 79 例。腦脊髓液分流和引流系統是適合所有年齡層診斷的腦積水病例的治療選擇。因此，腦脊髓液洩漏病例的增加促進了北美腦脊髓液管理市場的成長。

北美腦脊髓液管理市場概況

北美腦脊髓液管理市場分為美國、加拿大和墨西哥。美國在該地區佔有最大的市場佔有率。由於腦積水、創傷性腦損傷和其他神經系統疾病發病率的增加，預計該地區的市場在預測期內將繼續佔據主導地位；快速的技術創新；和發展醫療保健基礎設施。

北美腦脊髓液管理市場收入及 2030 年預測（百萬美元）

北美腦脊髓液管理市場細分

北美腦脊髓液管理市場分為產品、最終用戶和國家。

根據產品，北美腦脊髓液管理市場分為腦脊髓液分流器和腦脊髓液引流系統。 2022 年，CCS 分流器細分市場將佔據更大的市場。

根據最終用戶，北美腦脊髓液管理市場分為醫院、診所、門診手術中心等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家/地區分類，北美腦脊髓液管理市場分為美國、加拿大和墨西哥。 2022年，美國在北美腦脊髓液管理市場佔有率中佔據主導地位。

Argi Group Health Services Ltd Sti、B. Braun SE、BeckerSmith Medical Inc、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc、Sophysa SA 和 Spiegelberg GmbH & Co KG 是北美腦脊髓液領域的一些領先公司管理市場。

According to the Journal of Neurosurgery, more than 69 million people globally are estimated to suffer from traumatic brain injuries annually. Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leaks in adults, necessitating CSF management. High blood pressure, majorly caused due to a shift in lifestyle and unhealthy habits, is another notable cause of CSF leaks among adults and elderlies. Similarly, high blood pressure is common in elderly people, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH). Thus, the growing geriatric population can be associated with the growth of the North America cerebrospinal fluid management market.

The incidence of hydrocephalus is growing significantly across the world. The occurrence of hydrocephalus is highest in the geriatric population; notably, it is higher in the pediatric population compared to adults. According to an article published by the National Library of Medicine (NLM), the global prevalence of hydrocephalus is ~85 per 100,000 individuals. Per the same source, the prevalence rate in the pediatric population is ~88 per 100,000 whereas the rate is ~11 per 100,000 in adults and ~175 per 100,000 in the geriatric population. Further, the incidence rate of hydrocephalus in low- and medium-income countries is ~123 per 100,000 births whereas the rate in high-income countries is 79 per 100,000 births. The CSF shunts and drainage systems are the treatment options suitable for hydrocephalus cases diagnosed in people from all age groups. Hence, an increase in CSF leak cases boosts the growth of the North America cerebrospinal fluid management market.

North America Cerebrospinal Fluid Management Market Overview

The North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in this region. The market in this region is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure.

North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

North America Cerebrospinal Fluid Management Market Segmentation

The North America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the North America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the North America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US dominated the North America cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, BeckerSmith Medical Inc, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the North America cerebrospinal fluid management market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Cerebrospinal Fluid Management Market Landscape

4.1 Overview
4.2 North America PEST Analysis

5. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
- 5.1.2 Developments in CSF Management Products
5.2 Market Restraints
- 5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
- 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
- 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - North America Market Analysis

6.1 North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Ventriculoperitoneal Shunts
  - 7.3.3.1 Overview
  - 7.3.3.2 Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Ventriculoatrial Shunts
  - 7.3.4.1 Overview
  - 7.3.4.2 Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Ventriculopleural Shunts
  - 7.3.5.1 Overview
  - 7.3.5.2 Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Lumboperitoneal Shunts
  - 7.3.6.1 Overview
  - 7.3.6.2 Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 External Ventricular Drainage (EVD) Systems
  - 7.4.3.1 Overview
  - 7.4.3.2 External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
  - 7.4.4.1 Overview
  - 7.4.4.2 Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Cerebrospinal Fluid Management Market - Country Analysis

9.1 Overview

10. North America Cerebrospinal Fluid Management Market -Industry Landscape

10.1 Overview
10.2 Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 B. Braun SE
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Argi Group Health Services Ltd Sti
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Sophysa SA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BeckerSmith Medical Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Natus Medical Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Spiegelberg GmbH & Co KG
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Cerebrospinal Fluid Management Market Segmentation
Table 2. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 3. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 4. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 5. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 6. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 7. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 8. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 9. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 10. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
Table 11. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
Table 12. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
Table 13. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Recent Inorganic Growth Strategies in the North America Cerebrospinal Fluid Management Market
Table 15. Recent Organic Growth Strategies in The North America Cerebrospinal Fluid Management Market
Table 16. Glossary of Terms, North America Cerebrospinal Fluid Management Market

List Of Figures

Figure 1. North America Cerebrospinal Fluid Management Market Segmentation, By Country
Figure 2. North America - PEST Analysis
Figure 3. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
Figure 6. North America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
Figure 7. North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
Figure 17. Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
Figure 22. North America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
Figure 23. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023